Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
General Motors
GM
$76.5B
| $49.7M | 0.07% |
933,305
-1,583,117
| -63% | -$82.9M |
|
327
Madrigal Pharmaceuticals
MDGL
$12.5B
| $49.6M | 0.07% |
160,782
+116,285
| +261% | +$32.7M |
|
328
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
| $49.6M | 0.07% |
1,613,100
-28,100
| -2% | -$864K |
|
329
Willis Lease Finance
WLFC
$1.21B
| $49.4M | 0.07% |
713,691
-18,300
| -3% | -$1.19M |
|
330
Aon
AON
$74.7B
| $49.3M | 0.07% |
137,401
-43,900
| -24% | -$16.1M |
|
331
Arthur J. Gallagher & Co
AJG
$65.2B
| $49.2M | 0.07% |
173,200
+82,500
| +91% | +$24M |
|
|
HSII
332
DELISTED
Heidrick & Struggles
HSII
| $49M | 0.07% |
1,106,640
+39,800
| +4% | +$1.7M |
|
333
International Paper
IP
$21.8B
| $49M | 0.07% |
910,700
+452,500
| +99% | +$24.3M |
|
334
Warby Parker
WRBY
$3.12B
| $48.5M | 0.07% |
2,002,400
+313,100
| +19% | +$6.4M |
|
335
Kyndryl
KD
$2.78B
| $48.5M | 0.07% |
1,400,367
-817,633
| -37% | -$23.8M |
|
336
Edwards Lifesciences
EW
$53.3B
| $48.3M | 0.07% |
652,493
-569,207
| -47% | -$39.8M |
|
337
Dillards
DDS
$9.97B
| $48.2M | 0.07% |
111,700
-21,600
| -16% | -$8.86M |
|
338
Motorola Solutions
MSI
$77.1B
| $48.1M | 0.07% |
104,115
+61,000
| +141% | +$28.9M |
|
|
EMBJ
339
Embraer S.A. ADS
EMBJ
$13.1B
| $47.7M | 0.07% |
1,300,500
-181,300
| -12% | -$6.53M |
|
340
Collegium Pharmaceutical
COLL
$851M
| $47.6M | 0.07% |
1,661,549
+5,480
| +0.3% | +$181K |
|
341
Herbalife
HLF
$1.23B
| $47.4M | 0.07% |
7,088,868
+638,567
| +10% | +$4.74M |
|
342
DuPont de Nemours
DD
$19.3B
| $47.4M | 0.07% |
495,179
-239
| -0% | -$24.9K |
|
343
VanEck IG Floating Rate ETF
FLTR
$3.04B
| $47M | 0.07% |
1,847,800
+445,800
| +32% | +$11.3M |
|
344
Emcor
EME
$36.8B
| $47M | 0.07% |
103,520
-51,155
| -33% | -$24.2M |
|
345
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $46.9M | 0.07% |
466,400
+135,900
| +41% | +$13.7M |
|
346
Cisco
CSCO
$486B
| $46.6M | 0.07% |
786,705
-2,580,000
| -77% | -$147M |
|
347
Rocket Lab Corp
RKLB
$51.4B
| $46.3M | 0.07% |
1,818,800
+1,721,300
| +1,765% | +$30.2M |
|
348
Eldorado Gold
EGO
$10.5B
| $46M | 0.07% |
3,094,637
-209,000
| -6% | -$3.45M |
|
349
Carpenter Technology
CRS
$26.7B
| $46M | 0.07% |
270,900
-26,291
| -9% | -$4.51M |
|
350
Medtronic
MDT
$115B
| $46M | 0.07% |
575,341
-737,300
| -56% | -$63.8M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.